A

Artrya Ltd
ASX:AYA

Watchlist Manager
Artrya Ltd
ASX:AYA
Watchlist
Price: 3.77 AUD 9.28% Market Closed
Market Cap: 596m AUD

Artrya Ltd
Total Current Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Artrya Ltd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
A
Artrya Ltd
ASX:AYA
Total Current Assets
AU$17.1m
CAGR 3-Years
-23%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Mach7 Technologies Ltd
ASX:M7T
Total Current Assets
AU$30.3m
CAGR 3-Years
-2%
CAGR 5-Years
-11%
CAGR 10-Years
25%
4DMedical Ltd
ASX:4DX
Total Current Assets
AU$17.1m
CAGR 3-Years
-34%
CAGR 5-Years
10%
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Total Current Assets
$50.3m
CAGR 3-Years
6%
CAGR 5-Years
26%
CAGR 10-Years
20%
Pro Medicus Ltd
ASX:PME
Total Current Assets
AU$280.1m
CAGR 3-Years
33%
CAGR 5-Years
35%
CAGR 10-Years
32%
Alcidion Group Ltd
ASX:ALC
Total Current Assets
AU$23.7m
CAGR 3-Years
-3%
CAGR 5-Years
3%
CAGR 10-Years
20%
No Stocks Found

Artrya Ltd
Glance View

Market Cap
596m AUD
Industry
Health Care

Artrya Ltd. develops the Salix suite of products to address coronary artery disease (CAD). The company is headquartered in Perth, Western Australia. The company went IPO on 2021-11-26. The firm is focused on operating diagnostic imaging center. The company is primarily engaged in providing powered image-analysis software for coronary artery disease. Its non-invasive solution, Salix uses artificial intelligence (AI) to produce a 3D image and report that provides an accurate detection of coronary artery disease, including the presence of vulnerable plaque. Salix offers precision medicine for cardiac care. The company enables clinicians to triage patients and identify individuals at high risk of heart attack. The firm's cardiac-health report provides diagnostic support to radiologists and cardiologists.

AYA Intrinsic Value
2.65 AUD
Overvaluation 30%
Intrinsic Value
Price
A

See Also

What is Artrya Ltd's Total Current Assets?
Total Current Assets
17.1m AUD

Based on the financial report for Jun 30, 2025, Artrya Ltd's Total Current Assets amounts to 17.1m AUD.

What is Artrya Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
45%

Over the last year, the Total Current Assets growth was 49%. The average annual Total Current Assets growth rates for Artrya Ltd have been -23% over the past three years , 45% over the past five years .

Back to Top